PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Five Points Brewing Company are an independent craft brewery. Since the company started in 2013, the demand has risen beyond capacity and they are looking for investment to treble the capacity of their brewery and open a Tap Room on the five point’s junction they are named after.
days to go:
Expired
investment:
£1,141,840
Harvey’s British Eatery is a 35 to 40 cover eatery focused on re-establishing the heritage of British cooking. Harvey’s recipes draw on the best in the British Isles, using seasonal ingredients. The investment will be used to take their eatery to a permanent site in London.
(SEIS partial)
days to go:
Expired
investment:
£193,550
Fireaway pizza orginally started out as a modest pizzeria in south London in 2016, we've expanded to 159 franchises, achieving a remarkable 106% compound annual growth rate in store expansion. With franchise sales reaching £59 million annually, we became debt-free in 2022, boasting an EBITDA of £1.31 million and HQ revenue of £14.5 million in FY23. As a profitable venture, we invite you to join us and be part of our promising growth trajectory.
days to go:
Expired
investment:
£532,336
The UK's first authentic iced milk tea / brewed chai, combining the speciality of flavoured teas with the status of milk tea. Tuk Tuk Chai launched in 2017 with products available at 110 Sainsbury’s stores and Harvey Nichols. The firm has won multiple awards including 'Most Innovative Product' at the Lunch! 2017 trade show and were finalists for 2017 Virgin Foodpreneur. In 2018, Peter Jones of Dragon's Den made an investment offer towards the company.
days to go:
Expired
investment:
£275,920
A brewery, gin distillery, bar and kitchen business. Love Lane Brewery is based in Liverpool and produces around 18,000 hectolitres of beer per year. In 2017, the company generated revenues of £300k; in 2018, they achieved £1m in revenue and have 60 clients that sell their Love Lane Pale Ale. The company also offers an event space and tours of their sites.
Love Lane Brewery will invest in their brand by increasing their sale and distribution channels, with the intent of marketing their products directly to consumers. Funds will also be allocated towards their infrastructure, primarily in their warehouse and brewery to purchase equipment such as hop cannons, cold stores, racking, augers, etc.
days to go:
Expired
investment:
£1,051,680
